CC vs DVA · P/E 72, rev $1.36B vs P/E 14, rev $12.82B
Chemours Co (CC) versus DaVita HealthCare Partners Inc (DVA) — a side-by-side from cached financials, not a winner call.
Chemours Co (CC) is a specialty chemicals company listed on US.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
Latest reported CC revenue for 2024-12-31 was $1.36B. Net income was -$8.0M. Revenue was down 9.9% from 2024-09-30 to 2024-12-31. CC currently screens at market cap $1.94B and trailing P/E 71.8.
Latest reported DVA revenue for 2024-12-31 was $12.82B. Net income was $1.25B. Revenue was up 5.6% from 2023-12-31 to 2024-12-31. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
CC currently screens at market cap $1.94B and trailing P/E 71.8. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
Not investment advice. Open the CC and DVA stock pages for the full models.
Not investment advice.